Figure 5.
Thermal behavior of bevacizumab-loaded ESHU formulated with 20 wt% ESHU and 1.25 mg bevacizumab. The steep increase in G′ from 33 to 39 °C indicated a sol–gel phase transition. The phase transition behavior is similar to pure ESHU.[18]
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.